G-Rish Pharma Private Limited

G-Rish Pharma Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2022PTC386662 Incorporated 13 July 2022 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹31.8 Cr
Latest filing
Net profit · FY 2024
₹58.63 Lakh
Net margin 1.8%
EBITDA · FY 2024
₹1.25 Cr
EBITDA margin 3.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings

About G-Rish Pharma Private Limited

Data last updated:

G-Rish Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 July 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC386662.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vaibhav Saraf (Managing Director) and Gaurav Ajay Saraf.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No. 337 & 338 Bombay Oil Seeds Plot No. 2 3 & 4 Sector 19A Vashi, Navi Mumbai, Maharashtra, India – 400705.

As per the financials filed for FY 2024, the company reported a revenue of ₹31.8 Cr. For the same year it recorded a net profit of ₹58.63 Lakh (net margin 1.8%) and EBITDA of ₹1.25 Cr (EBITDA margin 3.9%).

The company is associated with 1 brand: G-Rish Pharma. As per MCA filings, the company has open charges of ₹5 Cr on record.

For more details, the company can be reached via its website g-rishpharma.com.

Company Details of G-Rish Pharma Private Limited
CIN U24230MH2022PTC386662
Registration Number 386662
Incorporation Date 13 July 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Office No. 337 & 338 Bombay Oil Seeds Plot No. 2 3 & 4 Sector 19A Vashi, Navi Mumbai, Maharashtra, India – 400705
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
G-Rish Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full G-Rish Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for G-Rish Pharma Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Business Activity of G-Rish Pharma Private Limited

The main business activity of G-Rish Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of G-Rish Pharma Private Limited FY 2025 filings available

G-Rish Pharma Private Limited reported revenue of ₹31.8 Cr for FY 2024.

Revenue · FY 2024
₹31.8 Cr
Net profit · FY 2024
₹58.63 Lakh margin 1.8%
EBITDA · FY 2024
₹1.25 Cr margin 3.9%

Financial Statement Summary of G-Rish Pharma Private Limited

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA₹1.25 Cr••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)₹58.63 Lakh••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of G-Rish Pharma Private Limited

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin3.9%••••
Net Profit Margin1.8%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of G-Rish Pharma are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of G-Rish Pharma Private Limited

G-Rish Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Debashu Services Private Limited₹31.83 Cr (FY 2025)••••••••59.0%••••Nagpur, Maharashtra, India
Citadel Eco-Build Private Limited₹31.83 Cr (FY 2025)••••••••19.0%••••Pune, Maharashtra, India
Space Office Systems (India) Private Limited₹31.82 Cr (FY 2024)••••••••12.0%••••Mumbai, Maharashtra, India
Accurate PMS Private Limited₹31.82 Cr (FY 2025)••••••••-3.0%••••Ahmedabad, Gujarat, India
Kota Agroprotiens Private Limited₹31.8 Cr (FY 2025)••••••••18.0%••••Kota, Rajasthan, India
G-Rish Pharma Private Limited this company₹31.8 Cr (FY 2024)••••••••••••Navi Mumbai, Maharashtra, India
Utkarsh Infotech Private Limited₹31.79 Cr (FY 2024)••••••••-20.0%••••Secunderabad, Telangana, India
Jay Shankar Agro Inputs Private Limited₹31.79 Cr (FY 2025)••••••••-25.0%••••Delhi, India
Pious Fashion Private Limited₹31.78 Cr (FY 2023)••••••••-38.0%••••Delhi, India
Mahaveer Salt Private Limited₹31.77 Cr (FY 2025)••••••••-16.0%••••Raipur, Chhattisgarh, India
Shaksham Agro Private Limited₹31.77 Cr (FY 2025)••••••••191.0%••••Howrah, West Bengal, India

Peers are the five companies nearest above and the five nearest below G-Rish Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of G-Rish Pharma Private Limited

G-Rish Pharma Private Limited is audited by S.M.AMERIA & ASSOCIATES for the financial year 2023.

NameStatusAppointment DateCessation Date
S.M.AMERIA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of G-Rish Pharma Private Limited

G-Rish Pharma has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vaibhav SarafManaging Director13 Jul 20224 Years 3 MonthsCurrent
Gaurav Ajay SarafDirector13 Jul 20224 Years 3 MonthsCurrent
Gunja Gaurav SarafDirector13 Jul 20224 Years 3 MonthsCurrent

Ownership and Shareholding of G-Rish Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of G-Rish Pharma Private Limited

Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.00 Cr
Latest charge details
DateLenderAmountStatus
29 Jun 2023Others₹5 CrOpen

Total charge records: 1 View all charges

Associated Brands with G-Rish Pharma Private Limited

G-Rish Pharma operates one associated brand: G-Rish Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
G-Rish Pharma supplies and exports APIs, excipients, and intermediates to the healthcare industry.g-rishpharma.com

Employees and EPFO Compliance at G-Rish Pharma Private Limited

G-Rish Pharma Private Limited has a workforce of 0 employees as of Apr 01, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on G-Rish Pharma Private Limited

G-Rish Pharma Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Gaurav Ajay Saraf was appointed as Director on 13 Jul 2022.

AGM
G-Rish Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
G-Rish Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others of Rs. 500.00 Lakh registered on 29 Jun 2023 with Charge ID 100751057 was modified on 15 Jun 2024.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100751057 was registered on 29 Jun 2023.
Appointed
Gaurav Ajay Saraf was appointed as Director.
Appointed
Gunja Gaurav Saraf was appointed as Director.
Appointed
Vaibhav Saraf was appointed as Managing Director.
Incorporation
13 Jul 2022
G-Rish Pharma Private Limited was registered on 13 Jul 2022 with Roc Mumbai Ii & aged 4 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for G-Rish Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by G-Rish Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of G-Rish Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of G-Rish Pharma Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of G-Rish Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about G-Rish Pharma Private Limited

G-Rish Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 July 2022 (4+ years old) and is registered under CIN U24230MH2022PTC386662.

G-Rish Pharma reported revenue of ₹31.8 Cr for FY 2024.

G-Rish Pharma has 3 current directors:

G-Rish Pharma reported a net profit of ₹58.63 Lakh (net margin 1.8%) and EBITDA of ₹1.25 Cr (EBITDA margin 3.9%) for FY 2024, as per its filed financial statements.

The CIN (Corporate Identification Number) of G-Rish Pharma is U24230MH2022PTC386662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

G-Rish Pharma was incorporated on 13 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of G-Rish Pharma by revenue are Debashu Services Private Limited, Citadel Eco-Build Private Limited, Space Office Systems (India) Private Limited, Accurate PMS Private Limited, Kota Agroprotiens Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).

Gaurav Ajay Saraf was appointed as Director on 13 Jul 2022. Gunja Gaurav Saraf was appointed as Director on 13 Jul 2022. Vaibhav Saraf was appointed as Managing Director on 13 Jul 2022.

G-Rish Pharma can be reached through the website g-rishpharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.

The registered office of G-Rish Pharma is at Office No. 337 & 338 Bombay Oil Seeds Plot No. 2 3 & 4 Sector 19A Vashi, Navi Mumbai, Maharashtra, India – 400705.

G-Rish Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available